We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutr... Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States. Show more
University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott PR Newswire ABBOTT PARK, Ill., and...
Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis PR Newswire ABBOTT PARK, Ill., Nov. 25, 2024 The investigational transcatheter...
Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland PR Newswire KILKENNY, Ireland, Nov. 18, 2024 An Taoiseach, Simon Harris, TD, and Abbott Chairman and Chief...
U.S. index futures rose in Friday’s pre-market, fueled by anticipation of key earnings reports from Chevron and Exxon Mobil, as investors awaited the crucial jobs report and the conclusion...
Amazon (NASDAQ:AMZN) – Amazon exceeded expectations for the third quarter with earnings per share of $1.43, compared to the anticipated $1.14, and revenue of $158.88 billion, surpassing...
Un nouveau rapport canadien montre qu'une attitude positive est préférable à la critique dans la prise en charge du diabète Canada NewsWire MISSISSAUGA, Ontario, le 30...
New Canadian Report Shows Positivity Instead of Criticism is Key in Diabetes Management Canada NewsWire MISSISSAUGA, ON, Oct. 30, 2024 Canadians living with type 2 diabetes agree that uplifting...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.2 | -1.87873612297 | 117.1 | 117.44 | 113.85 | 4377061 | 115.65372373 | CS |
4 | -2.1 | -1.79487179487 | 117 | 120.53 | 113.85 | 4809409 | 116.68404188 | CS |
12 | -2.9 | -2.46179966044 | 117.8 | 120.9 | 111.68 | 5114754 | 115.84332378 | CS |
26 | 7.59 | 7.07296617277 | 107.31 | 120.9 | 99.71 | 5598877 | 110.97847437 | CS |
52 | 10.69 | 10.2581326168 | 104.21 | 121.64 | 99.71 | 5592750 | 110.68952016 | CS |
156 | -18.67 | -13.977689601 | 133.57 | 142.6 | 89.674 | 5434748 | 109.50611219 | CS |
260 | 31.02 | 36.9814020029 | 83.88 | 142.6 | 61.61 | 5645481 | 107.20022685 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions